Phase II Trial of Erlotinib, Prior to Surgery or Radiation in Patients With Squamous Cell Cancers (SCC) of the Skin

Sponsor and Collaborators     
M.D. Anderson Cancer Center
OSI Pharmaceuticals

Contact
Bonnie S. Glisson, MD, BS     713-792-6363     


Continue Reading

Investigator    
Bonnie S. Glisson, MD, BS     UT MD Anderson Cancer Center

ClinicalTrials.gov Identifier
NCT01059305